Sepp-Lorenzino Laura 4
4 · Intellia Therapeutics, Inc. · Filed Jan 10, 2024
Insider Transaction Report
Form 4
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-08$29.38/sh−667$19,596→ 43,927 total - Sale
Common Stock
2024-01-08$28.66/sh−1,608$46,085→ 44,594 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.16 to $29.06, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 8, 2024 at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.19 to $29.63, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 8, 2024 at each separate price.